Qualmed Health Sciences Limited
Introduction
Qualmed Health Sciences Limited is an innovative pharmaceutical manufacturer and Contract Development and Manufacturing Organization (CDMO), specializing in advanced drug delivery technologies and high-quality formulations. Based in Hyderabad, India, Qualmed is committed to scientific research, cutting-edge formulation techniques, and regulatory compliance, making it a trusted partner for global pharmaceutical and healthcare companies.
Core Business & Specialization
Qualmed Health Sciences Limited focuses on research-driven pharmaceutical formulations and novel drug delivery systems, offering expertise in:
- Oral Thin Film Technology (OTF) – AirSol® technology for rapid drug absorption and patient convenience.
- Oral Solid Dosage Forms (OSD) – High-quality tablets and capsules with controlled-release mechanisms.
- Liquid Formulations – Syrups and suspensions for pediatric, geriatric, and general healthcare applications.
- Semi-Solid Dosage Forms – Creams and ointments designed for dermatological and topical treatments.
The company’s scientifically validated formulations ensure enhanced bioavailability, stability, and patient compliance.
Product Portfolio
Qualmed Health Sciences offers a diverse range of pharmaceutical formulations under its own brands and as a CDMO for global pharmaceutical companies:
1. Oral Thin Films (OTF)
- AirSol® Technology – A patented thin-film drug delivery system providing rapid dissolution and effective absorption.
2. Oral Solid Dosage (OSD)
- Tablets & Capsules – Immediate-release, extended-release, and enteric-coated formulations.
3. Liquid Formulations
- Syrups & Suspensions – Custom formulations for therapeutic treatments.
4. Semi-Solid Dosage Forms
- Creams & Ointments – Designed for dermatology, pain relief, and wound care applications.
All products are manufactured under stringent quality control protocols, adhering to global pharmaceutical standards.
Manufacturing Capabilities
Qualmed Health Sciences operates state-of-the-art, GMP-compliant manufacturing facilities, featuring:
- Patented Drug Delivery Technologies – AirSol® for fast-acting and enhanced drug bioavailability.
- ISO & GMP-Certified Production – Ensuring quality, consistency, and regulatory compliance.
- Advanced Quality Control & R&D – Equipped with analytical testing, stability studies, and formulation development.
The company supports customized pharmaceutical solutions, making it a preferred contract manufacturer for global pharmaceutical brands.
Financial Performance & Market Presence
- Annual Revenue: Estimated at ₹100-150 crore ($12-18 million).
- Global Market Reach: Supplying to over 20 countries, including North America, Europe, and Southeast Asia.
- Strategic Partnerships: Collaborating with leading pharmaceutical companies and research institutions.
Qualmed’s focus on high-value pharmaceutical innovation has positioned it as a key player in the drug delivery technology sector.
Certifications & Compliance
Qualmed Health Sciences Limited complies with strict global regulatory standards, holding certifications such as:
- GMP (Good Manufacturing Practices) Certified
- ISO 22000:2018 (Food Safety Management System)
- USFDA & EMA Regulatory Compliance
- HACCP (Hazard Analysis and Critical Control Points)
- FSSAI (Food Safety and Standards Authority of India)
These certifications reinforce Qualmed’s commitment to safety, efficacy, and pharmaceutical innovation.
Logistics & Shipment Data
- Total Shipments in 2023: Over 1,200+ global shipments.
- Export Value: Estimated at $8+ million in pharmaceutical exports.
- Warehousing & Distribution: Strategic distribution centers in India, Europe, and the U.S..
- Logistics Partnerships: Works with DHL, FedEx, and pharmaceutical-grade logistics firms.
Qualmed’s global supply chain infrastructure ensures timely and efficient delivery of pharmaceutical products worldwide.
Customer Testimonials
Qualmed Health Sciences is recognized by leading pharmaceutical brands and healthcare professionals:
- "AirSol® oral thin films are a game-changer in rapid drug delivery and patient compliance." – Pharmaceutical R&D Director.
- "Qualmed’s contract manufacturing services provide high-quality formulations that meet global regulatory standards." – CEO, Pharmaceutical Company.
- "Their innovative drug delivery solutions help improve bioavailability and treatment outcomes." – Healthcare Specialist.
Major Achievements
- Ranked among India’s Top 10 Pharmaceutical Innovation Companies in 2023.
- Winner of "Best Novel Drug Delivery Technology" for AirSol® in 2023.
- Expanded into European and Southeast Asian markets, increasing global sales by 25%.
- Developed customized pharmaceutical solutions for leading global drug manufacturers.
Future Outlook
Qualmed Health Sciences aims to strengthen its global pharmaceutical presence by:
- Expanding into North American and Middle Eastern pharmaceutical markets.
- Increasing R&D investment in next-generation drug delivery systems.
- Developing biodegradable and plant-based thin-film drug technologies.
With its commitment to pharmaceutical innovation, regulatory compliance, and high-quality manufacturing, Qualmed Health Sciences is set to become a leader in advanced drug delivery solutions worldwide.
